Trials / Completed
CompletedNCT03287115
Biomarkers of Broccoli Intake: A Pilot Study
Biomarkers of Broccoli Intake: A Pilot Study to Characterize Novel Metabolites by Targeted Metabolic Profiling and Non-Targeted Metabolomics
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- USDA Beltsville Human Nutrition Research Center · Federal
- Sex
- All
- Age
- 21 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The objectives of the study are 1) to characterize plasma and urinary metabolites that originate from glucobrassicin, 1-methoxyglucobrassicin, 4-methoxyglucobrassicin, and 4-hydroxyglucobrassicin, which are the major indole glucosinolates found in broccoli, and 2) to identify novel plasma and urinary metabolites following broccoli consumption that may have roles in reducing the risk of cancer.
Detailed description
Consumption of Brassica vegetables is inversely associated with incidence of several cancers, including cancer of the lung, stomach, liver, colon, rectum, breast, endometrium, and ovaries. Brassicas are a good source of many nutrients, but the unique characteristic of Brassicas is their rich content of glucosinolates. Breakdown products of indole glucosinolates in Brassica vegetables show promise for reducing the risk of cancer, but have received comparatively less research attention than those of aliphatic glucosinolates. The aim of this study is to investigate plasma and urinary metabolites of indole glucosinolates from broccoli and to identify novel metabolites that may have roles in reducing cancer risk.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Broccoli consumption | All subjects will eat broccoli on day 11 |
Timeline
- Start date
- 2017-11-06
- Primary completion
- 2017-11-17
- Completion
- 2017-11-17
- First posted
- 2017-09-19
- Last updated
- 2017-11-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03287115. Inclusion in this directory is not an endorsement.